Orbital Global Group

Sudocrem family of products

Sudocrem leading consumer healthcare brand

From being one of the first licensed medicines to adopt social media, to developing scalable campaigns that easily transfer across multiple international territories, our approach to this iconic brand has been to dominate through innovation and creativity.

A key foundation of this success was the development of many new product claims via Orbital's pioneering Digital Real World Evidence research methodology. This saved vast sums of money in randomised clinical trials and redefined the product’s marketing capabilities. Market dominance and new product launches have since been made possible.

Our digital campaigns, platforms, gamification, animations, graphic design, 3D models, pharmacovigilance, groundbreaking AI and strategic understanding, continue to propel Sudocrem towards world leading brand status.

Our digital activity for Sudocrem has reached over 500 million people and resulted in over 10x prestigious awards.


Company details

Biotechnology and pharmaceuticals
"Since 2010 Orbital have been integral to digital strategy and delivery for our Sudocrem portfolio. Ongoing innovative strategies, extensive diligence and a desire to see the brand remain the market leader make Orbital a pleasure to work with. Orbital’s work with Sudocrem over the past decade has been extensively recognised, collecting numerous, prestigious industry accolades both in the UK and internationally."
Nicholas Lang TEVA OTC Director TEVA Pharmaceuticals